Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.
2007
969
LTM Revenue $93.6M
LTM EBITDA $16.1M
$199M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Selvita has a last 12-month revenue of $93.6M and a last 12-month EBITDA of $16.1M.
In the most recent fiscal year, Selvita achieved revenue of $87.8M and an EBITDA of $14.2M.
Selvita expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Selvita valuation multiples based on analyst estimatesFY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $89.1M | $87.8M | XXX | XXX | XXX |
Gross Profit | $87.1M | $70.8M | XXX | XXX | XXX |
Gross Margin | 98% | 81% | XXX | XXX | XXX |
EBITDA | $31.9M | $14.2M | XXX | XXX | XXX |
EBITDA Margin | 36% | 16% | XXX | XXX | XXX |
Net Profit | $7.8M | $17.9M | XXX | XXX | XXX |
Net Margin | 9% | 20% | XXX | XXX | XXX |
Net Debt | $13.3M | $20.5M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Selvita's stock price is PLN 32 (or $8).
Selvita has current market cap of PLN 580M (or $149M), and EV of PLN 776M (or $199M).
See Selvita trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$199M | $149M | XXX | XXX | XXX | XXX | $0.03 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Selvita has market cap of $149M and EV of $199M.
Selvita's trades at 2.1x LTM EV/Revenue multiple, and 12.4x LTM EBITDA.
Analysts estimate Selvita's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Selvita and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $199M | XXX | XXX | XXX |
EV/Revenue | 2.3x | XXX | XXX | XXX |
EV/EBITDA | 14.0x | XXX | XXX | XXX |
P/E | -95.1x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 17.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpSelvita's NTM/LTM revenue growth is 17%
Selvita's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Selvita's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Selvita's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Selvita and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -1% | XXX | XXX | XXX | XXX |
EBITDA Margin | 16% | XXX | XXX | XXX | XXX |
EBITDA Growth | -56% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 33% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
Opex to Revenue | 78% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Jubilant Pharmova | XXX | XXX | XXX | XXX | XXX | XXX |
Biocon | XXX | XXX | XXX | XXX | XXX | XXX |
Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
Dishman Carbogen Amics | XXX | XXX | XXX | XXX | XXX | XXX |
Suven Pharma | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Selvita acquired XXX companies to date.
Last acquisition by Selvita was XXXXXXXX, XXXXX XXXXX XXXXXX . Selvita acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Selvita founded? | Selvita was founded in 2007. |
Where is Selvita headquartered? | Selvita is headquartered in Poland. |
How many employees does Selvita have? | As of today, Selvita has 969 employees. |
Is Selvita publicy listed? | Yes, Selvita is a public company listed on WAR. |
What is the stock symbol of Selvita? | Selvita trades under SLV ticker. |
When did Selvita go public? | Selvita went public in 2019. |
Who are competitors of Selvita? | Similar companies to Selvita include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics. |
What is the current market cap of Selvita? | Selvita's current market cap is $149M |
What is the current revenue of Selvita? | Selvita's last 12-month revenue is $93.6M. |
What is the current EBITDA of Selvita? | Selvita's last 12-month EBITDA is $16.1M. |
What is the current EV/Revenue multiple of Selvita? | Current revenue multiple of Selvita is 2.1x. |
What is the current EV/EBITDA multiple of Selvita? | Current EBITDA multiple of Selvita is 12.4x. |
What is the current revenue growth of Selvita? | Selvita revenue growth between 2023 and 2024 was -1%. |
Is Selvita profitable? | Yes, Selvita is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.